Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elicio Therapeutics, Inc. | 41,600 | reported | 02 Feb 2026 | tx 10+167,485−743 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Elicio Therapeutics, Inc. | 20,800 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | Elicio Therapeutics, Inc. | 41,600 | 0.00 USD | deriv |
| 09 Dec 2025 | EXERCISE | Elicio Therapeutics, Inc. | 362 | 4.41 USD | |
| 09 Dec 2025 | EXERCISE | Elicio Therapeutics, Inc. | 362 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 44,400 | 0.00 USD | deriv |
| 16 Dec 2024 | EXERCISE | Elicio Therapeutics, Inc. | 381 | 4.41 USD | |
| 16 Dec 2024 | EXERCISE | Elicio Therapeutics, Inc. | 381 | 0.00 USD | deriv |
| 30 Sept 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 29,800 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 29,800 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 342 | 0.00 USD | deriv |